{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:28:54Z","timestamp":1787009334380,"version":"build-2736575974"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pustulotic arthro-osteitis (PAO) is an inflammatory osteoarticular disorder associated with palmoplantar pustulosis (PPP). Whilst anti-TNF-\u03b1 agents and IL-23 inhibitors have shown efficacy in PAO, the therapeutic potential of bimekizumab (BKZ), a dual IL-17A and IL-17F inhibitor, remains unestablished. A 53-year-old Japanese man with a history of PPP developed fever and polyarthritis involving the distal interphalangeal joints, shoulders, and knees. Laboratory investigations revealed elevated inflammatory markers, including C-reactive protein and matrix metalloproteinase-3. Imaging studies showed inflammation of the sternum and sacroiliac joints, consistent with PAO. Despite treatment with nonsteroidal anti-inflammatory drugs, methotrexate, adalimumab, and upadacitinib, his symptoms and systemic inflammation persisted. Bacterial cultures were negative, and no other causes of fever were identified. The patient became afebrile the day after switching to BKZ, and both joint and skin symptoms gradually improved thereafter, along with normalisation of laboratory markers. This case highlights the potential utility of BKZ in the treatment of refractory PAO, particularly in cases with systemic inflammation and fever.<\/jats:p>","DOI":"10.1093\/mrcr\/rxaf078","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T13:09:23Z","timestamp":1763644163000},"source":"Crossref","is-referenced-by-count":2,"title":["Successful treatment of pustulotic arthro-osteitis with bimekizumab: a case report"],"prefix":"10.1093","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4565-879X","authenticated-orcid":false,"given":"Masahiro","family":"Kogami","sequence":"first","affiliation":[{"name":"Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Shirayanagi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Makiyama","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurisu","family":"Tada","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Yamaji","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Tamura","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"2025120408515886800_ref1","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.crad.2011.08.014","article-title":"SAPHO: What radiologists should know","volume":"67","author":"Depasquale","year":"2012","journal-title":"Clin Radiol"},{"key":"2025120408515886800_ref2","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1093\/mr\/roab103","article-title":"SAPHO syndrome and pustulotic arthro-osteitis","volume":"32","author":"Kishimoto","year":"2022","journal-title":"Mod Rheumatol"},{"key":"2025120408515886800_ref3","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s13075-022-02934-3","article-title":"Efficacy and safety of guselkumab and adalimumab for pustulotic arthro-osteitis and their impact on peripheral blood immunophenotypes","volume":"24","author":"Ueno","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"2025120408515886800_ref4","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1111\/j.1600-0625.2011.01325.x","article-title":"Patients with palmoplantar pustulosis have increased IL-17 and IL-22 levels both in the lesion and serum","volume":"20","author":"Murakami","year":"2011","journal-title":"Exp Dermatol"},{"key":"2025120408515886800_ref5","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.jaad.2019.01.066","article-title":"Secukinumab for moderate-to-severe palmoplantar pustular psoriasis: Results of the 2PRECISE study","volume":"80","author":"Mrowietz","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"2025120408515886800_ref6","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s40257-024-00876-x","article-title":"Efficacy and safety of Brodalumab, an anti-interleukin-17 receptor a monoclonal antibody, for palmoplantar pustulosis: 16-week results of a randomized clinical trial","volume":"25","author":"Okubo","year":"2024","journal-title":"Am J Clin Dermatol"},{"key":"2025120408515886800_ref7","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 rheumatoid arthritis classification criteria: An American College of Rheumatology\/European league against rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2025120408515886800_ref8","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1093\/mr\/roae003","article-title":"Modified pustulotic arthro-osteitis diagnostic guidance 2022 - modified Sonozaki criteria - secondary publication","volume":"34","author":"Tsuji","year":"2024","journal-title":"Mod Rheumatol"},{"key":"2025120408515886800_ref9","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.40.6.554","article-title":"Incidence of arthro-osteitis in patients with pustulosis palmaris et plantaris","volume":"40","author":"Sonozaki","year":"1981","journal-title":"Ann Rheum Dis"},{"key":"2025120408515886800_ref10","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1111\/1346-8138.12272","article-title":"Pustulotic arthro-osteitis associated with palmoplantar pustulosis","volume":"40","author":"Yamamoto","year":"2013","journal-title":"J Dermatol"},{"key":"2025120408515886800_ref11","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1136\/annrheumdis-2017-212127","article-title":"Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: Evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation","volume":"77","author":"Glatt","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2025120408515886800_ref12","doi-asserted-by":"crossref","first-page":"2280508","DOI":"10.1080\/09546634.2023.2280508","article-title":"Palmoplantar pustulosis with psoriatic arthritis ineffective to interleukin-17 inhibitors: Two patients successfully treated with upadacitinib","volume":"34","author":"Zhang","year":"2023","journal-title":"J Dermatolog Treat"},{"key":"2025120408515886800_ref13","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jaad.2016.07.058","article-title":"Secukinumab shows significant efficacy in palmoplantar psoriasis: Results from GESTURE, a randomized controlled trial","volume":"76","author":"Gottlieb","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"2025120408515886800_ref14","doi-asserted-by":"publisher","first-page":"e30065","DOI":"10.1097\/MD.0000000000030065","article-title":"Exceptional response of skin symptoms to secukinumab treatment in a patient with SAPHO syndrome: Case report and literature review","volume":"101","author":"Ji","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"2025120408515886800_ref15","doi-asserted-by":"publisher","first-page":"109694","DOI":"10.1016\/j.clim.2023.109694","article-title":"Local injection of micro-dose anti-interleukin-17A antibody for palmoplantar pustulosis: A real-world study","volume":"253","author":"Xia","year":"2023","journal-title":"Clin Immunol"},{"key":"2025120408515886800_ref16","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1111\/ced.15087","article-title":"Successful treatment of synovitis, acne, pustulosis, hyperostosis and osteitis syndrome with ixekizumab","volume":"47","author":"Xia","year":"2022","journal-title":"Clin Exp Dermatol"},{"key":"2025120408515886800_ref17","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1001\/jamadermatol.2023.5051","article-title":"Treatment of severe palmoplantar pustular psoriasis with Bimekizumab","volume":"160","author":"Passeron","year":"2024","journal-title":"JAMA Dermatol"},{"key":"2025120408515886800_ref18","doi-asserted-by":"crossref","first-page":"e5724","DOI":"10.1097\/MD.0000000000005724","article-title":"The coexistence of SAPHO syndrome and rheumatoid arthritis: A case report","volume":"96","author":"Xu","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"2025120408515886800_ref19","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.jbspin.2013.03.020","article-title":"Coexistence of seropositive rheumatoid arthritis and SAPHO syndrome","volume":"80","author":"Nissen","year":"2013","journal-title":"Joint Bone Spine"},{"key":"2025120408515886800_ref20","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1007\/s00296-023-05491-3","article-title":"SAPHO syndrome: Current clinical, diagnostic and treatment approaches","volume":"44","author":"Demirci Yildirim","year":"2024","journal-title":"Rheumatol Int"},{"key":"2025120408515886800_ref21","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/bjd\/ljaf032","article-title":"Bimekizumab efficacy and safety through 3\u00a0years in patients with moderate-to-severe plaque psoriasis: Long-term results from the BE RADIANT phase IIIb trial open-label extension period","volume":"193","author":"Warren","year":"2025","journal-title":"Br J Dermatol"},{"key":"2025120408515886800_ref22","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14155421","article-title":"Comparative analysis of the long-term real-world efficacy of Interleukin-17 inhibitors in a cohort of patients with moderate-to-severe psoriasis treated in Poland","volume":"14","author":"Kruczek","year":"2025","journal-title":"J Clin Med"}],"container-title":["Modern Rheumatology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mrcr\/advance-article-pdf\/doi\/10.1093\/mrcr\/rxaf078\/65498892\/rxaf078.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/9\/2\/rxaf078\/65498892\/rxaf078.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/9\/2\/rxaf078\/65498892\/rxaf078.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T13:52:04Z","timestamp":1764856324000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mrcr\/article\/doi\/10.1093\/mrcr\/rxaf078\/8342256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,7,25]]}},"URL":"https:\/\/doi.org\/10.1093\/mrcr\/rxaf078","relation":{},"ISSN":["2472-5625"],"issn-type":[{"value":"2472-5625","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025]]},"published":{"date-parts":[[2025]]},"article-number":"rxaf078"}}